At present, the expression patterns of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor type 2 (HER2) in different subtypes of BC represent a predictive method for the therapeutic guidance of BC. Here, ERBB2 is linked to breast cancer.